Karosanidze, I.; Kiladze, U.; Kirtadze, N.; Giorgadze, M.; Amashukeli, N.; Parulava, N.; Iluridze, N.; Kikabidze, N.; Gudavadze, N.; Gelashvili, L.;
et al. Efficacy of Adaptogens in Patients with Long COVID-19: A Randomized, Quadruple-Blind, Placebo-Controlled Trial. Pharmaceuticals 2022, 15, 345.
https://doi.org/10.3390/ph15030345
AMA Style
Karosanidze I, Kiladze U, Kirtadze N, Giorgadze M, Amashukeli N, Parulava N, Iluridze N, Kikabidze N, Gudavadze N, Gelashvili L,
et al. Efficacy of Adaptogens in Patients with Long COVID-19: A Randomized, Quadruple-Blind, Placebo-Controlled Trial. Pharmaceuticals. 2022; 15(3):345.
https://doi.org/10.3390/ph15030345
Chicago/Turabian Style
Karosanidze, Irina, Ushangi Kiladze, Nino Kirtadze, Mikhail Giorgadze, Nana Amashukeli, Nino Parulava, Neli Iluridze, Nana Kikabidze, Nana Gudavadze, Lali Gelashvili,
and et al. 2022. "Efficacy of Adaptogens in Patients with Long COVID-19: A Randomized, Quadruple-Blind, Placebo-Controlled Trial" Pharmaceuticals 15, no. 3: 345.
https://doi.org/10.3390/ph15030345
APA Style
Karosanidze, I., Kiladze, U., Kirtadze, N., Giorgadze, M., Amashukeli, N., Parulava, N., Iluridze, N., Kikabidze, N., Gudavadze, N., Gelashvili, L., Koberidze, V., Gigashvili, E., Jajanidze, N., Latsabidze, N., Mamageishvili, N., Shengelia, R., Hovhannisyan, A., & Panossian, A.
(2022). Efficacy of Adaptogens in Patients with Long COVID-19: A Randomized, Quadruple-Blind, Placebo-Controlled Trial. Pharmaceuticals, 15(3), 345.
https://doi.org/10.3390/ph15030345